Approvals/TGA/APO-Bivalirudin bivalirudin (as trifluoroacetate) 250mg powder for injection vial

Approved

STANDARD

APO-Bivalirudin bivalirudin (as trifluoroacetate) 250mg powder for injection vial

Arrotex Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: f599ff48d64ec29a
Product Name: APO-Bivalirudin bivalirudin (as trifluoroacetate) 250mg powder for injection vial
Artg Id: 241713
Artg Name: APO-Bivalirudin bivalirudin (as trifluoroacetate) 250mg powder for injection vial
Sponsor: Arrotex Pharmaceuticals Pty Ltd
Company Detail Path: /organization/arrotex-pharmaceuticals-pty-ltd
Artg Date: 2016-05-17
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

f599ff48d64ec29a

Type

Standard